News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AvidBiotics Receives Two New Grants for Narrow-Spectrum Antibacterial Proteins, Bringing Total National Institutes of Health (NIH) Funding to Date to $4 Million



10/14/2010 9:36:51 AM

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--AvidBiotics today announced the receipt of two new grants totaling $1 million dollars from the National Institutes of Health that further the development of the company’s novel Avidocin™ platform for narrow spectrum antibacterial proteins against important health care threats. These grants add to three previous grants covering AvidBiotics’ anti-infectious disease technologies, which provide approximately $3.4 million in currently active funding for the company.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES